Wefers, A. K. Et Al. 2020. Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course. ACTA NEUROPATHOLOGICA , vol.139, no.1 , 193-209.

Wefers, A. K., Stichel, D., Schrimpf, D., Coras, R., Pages, M., Tauziede-Espariat, A., ... Varlet, P.(2020). Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course. ACTA NEUROPATHOLOGICA , vol.139, no.1, 193-209.

Wefers, Annika Et Al. "Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course," ACTA NEUROPATHOLOGICA , vol.139, no.1, 193-209, 2020

Wefers, Annika K. Et Al. "Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course." ACTA NEUROPATHOLOGICA , vol.139, no.1, pp.193-209, 2020

Wefers, A. K. Et Al. (2020) . "Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course." ACTA NEUROPATHOLOGICA , vol.139, no.1, pp.193-209.

@article{article, author={Annika K. Wefers Et Al. }, title={Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course}, journal={ACTA NEUROPATHOLOGICA}, year=2020, pages={193-209} }